Coherus BioSciences (CHRS) Defended at Citi, Analyst Says Buy Weakness - Bloomberg

November 7, 2016 1:20 PM EST
Get Alerts CHRS Hot Sheet
Price: $27.90 +1.27%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade CHRS Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Coherus BioSciences (NASDAQ: CHRS) Defended at Citi, Analyst Says Buy Weakness - Bloomberg



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Hot Comments, Trader Talk

Related Entities

Citi

Add Your Comment